Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.

Ion Agirrezabal Victoria K Brennan Fabien Colaone Suki Shergill Helena Pereira Gilles Chatellier Valérie Vilgrain

Published in: Advances in therapy (2022)

TARE using SIR-Spheres may achieve similar TTD in QOL compared with atezolizumab-bevacizumab, as the analyses found no statistically significant differences between these two interventions. Both TARE using SIR-Spheres and atezolizumab-bevacizumab seem to be more efficacious than sorafenib in maintaining QOL.

Keyphrases

metastatic colorectal cancer
liver metastases
locally advanced
radiation therapy
radiofrequency ablation
rectal cancer